Alzamend Neuro (ALZN) has released an update to notify the public and investors about the unregistered sales of equity securities.
The Current Report on Form 8-K indicates that Series A Convertible Preferred Stock and Warrants were sold to a Purchaser under an exemption from registration requirements pursuant to Section 4(a)(2) of the Securities Act of 1933.
For further insights into ALZN stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.